The record project. Continuous blood glucose monitoring among high-risk subjects for developing diabetes in Spanish primary health care;El proyecto RECORD (Registro Continuo de la Glucemia en Sujetos de Alto Riesgo para la Diabetes Tipo 2). Diseño y aplicación en atención primaria de salud

Atencion Primaria

Volumn 35, Issue 2, 2005, Pages 99-104

  Costa, Bernardo ^a,b   Vizcaino J ^a   Pinol J L ^a   Martin F ^a   Cabre J J ^a   Basora, J ^a  

^a INSTITUT CATALÀ DE LA SALUT   (Spain)

^b Centro de Diabetes Salou   (Spain)

Author keywords

Continuous blood glucose monitoring; Diabetes; Impaired fasting glucose; Impaired glucose tolerance; Prediabetes

Indexed keywords

C PEPTIDE; GLUCOSE;

ACCURACY; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; COMPARATIVE STUDY; COMPUTER ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEMOGRAPHY; DIAGNOSTIC TEST; DIET RESTRICTION; DISEASE MARKER; FEASIBILITY STUDY; FEMALE; FOLLOW UP; GLUCOSE ASSAY; GLUCOSE BLOOD LEVEL; HIGH RISK PATIENT; HUMAN; HYPERGLYCEMIA; INCIDENCE; INFLAMMATION; INSULINEMIA; LONGITUDINAL STUDY; MALE; METABOLIC SYNDROME X; MICRODIALYSIS; MONITORING; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PHASE 1 CLINICAL TRIAL; POSTPRANDIAL STATE; PRIMARY MEDICAL CARE; QUALITY OF LIFE; SENSOR; SPAIN;

EID: 16844364666     PISSN: 02126567     EISSN: None     Source Type: Journal    
DOI: 10.1157/13071917     Document Type: Article

References (20)

1. American Diabetes Association Position Statements. Screening for Type 2 Diabetes. Diabetes Care 2004;27:S11-S4.
2. World Health Organization. Report of a WHO Consultation. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Geneva: World Health Organization. Department of Non Communicable Disease Surveillance, 1999.
3. Djakoure-Platonoff C, Radermercker R, Reach G, Slama G, Selam JI. Accuracy of the continuous glucose monitoring system in inpatient and outpatient conditions. Diabetes Metab 2003;29:159-62.
4. Maran A, Crepaldi C, Tiengo A, Grassi G, Vitali E, Pagano G, et al. Continuous subcutaneous glucose monitoring in diabetic patients: a multicenter analysis. Diabetes Care 2002;25:347-52.
5. Chico A, Vidal-Ríos P, Subira M, Novials A. The continuous glucose monitoring system is useful for detecting unrecognized hypoglycemia in patients with type 1 and type 2 diabetes but is not better than frequent capillary glucose measurements for improving metabolic control. Diabetes Care 2003;26:1153-7.
6. López-Siguero JP, Garcia Arias MJ, Del Pino de la Fuente A, Moreno Molina JA. Continuous glucose monitoring with type 1 diabetes mellitus. An Pediatr (Barc) 2003;58:217-21.
7. Weinzimer SA, DeLucia MC, Boland EA, Steffen A, Tamborlane WV. Analysis of continuous glucose monitoring data from non-diabetic and diabetic children: a tale of two algorithms. Diabetes Technol Ther 2003;5:375-80.
8. Ludvigsson J, Hanas R. Continuous subcutaneous glucose monitoring improved metabolic control in pediatric patients with type 1 diabetes: a controlled crossover study. Pediatrics 2003;111:933-8.
9. Costa B, Franch J, Martín F, Morató J, Donado A, Basora J, et al, IGT Research Group. Impact of the American Diabetes Association Diagnosis Criteria on High-Risk Spanish Population. Diab Res Clin Pract 1999;46:75-81.
10. De Vegt F, Dekker JM, Jager A, Hienkens E, Kostense PJ, Stehouwer CD, et al. Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: the Hoorn Study. JAMA 2001;285:2109-13.
11. Salardi S, Zucchini S, Santoni R, Ragni L, Gualandi S, Cicognani A, et al. The glucose area under the profiles obtained with continuous glucose monitoring system relationships with HbA(1c) in pediatric type 1 diabetic patients. Diabetes Care 2002;25:1840-4.
12. Grupo de Trabajo Resistencia a la Insulina de la Sociedad Española de Diabetes. Resistencia a la insulina y su implicación en múltiples factores asociados a diabetes tipo 2. Med Clin (Barc) 2002;119:458-63.
13. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001;285: 2486-97.
14. Varalli M, Marelli G, Maran A, Bistoni S, Luzzana M, Cremonesi P, et al. A microdialysis technique for continuous subcutaneous glucose monitoring in diabetic patients (part 2). Biosens Bioelectron 2003;18:899-905.
15. Costa B, Martín F, Donado A, Parera F, Piñol JL, Basora J, et al y el Grupo de Investigación ITG (Reus-Tarragona). Diabetes ignorada y otras alteraciones del metabolismo glucídico en la población española de alto riesgo. El Estudio ITG. Med Clin (Barc) 2000;114:601-8.
16. Guerci B. Asymptomatic glycemic instability: how to measure it and which clinical applications? Diabetes Metab 2003;29:179-88.
17. Hay LC, Wilmshurst EG, Fulcher G. Unrecognized hypo- and hyperglycemia in well-controlled patients with type 2 diabetes mellitus: the results of continuous glucose monitoring. Diabetes Technol Ther 2003;5:19-26.
18. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343-50.
19. Vázquez JA, Gaztambide S, Soto-Pedre E. Estudio prospectivo a 10 años sobre la incidencia y factores de riesgo de diabetes mellitus tipo 2. Med Clin (Barc) 2000;115:534-9.
20. Costa B, Piñol JL, Donado A, Martín F, Castell C y el Grupo de Investigación ITG (Reus-Tarragona). Incidencia significativa de la diabetes tipo 2 en la población española de alto riesgo. Resultados del estudio ITG(2). Med Clin (Barc) 2002;118:287-93.